Waystar Holding Corp.
WAY Mid CapHealthcare · Health Information Services
Updated: Jun 14, 2026, 22:19 UTC
Price Chart
Key Metrics
Valuation Analysis
About the Company
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.
Waystar Holding Corp. Stock at a Glance
Waystar Holding Corp. (WAY) is currently trading at $18.75 with a market capitalization of $3.6B. The trailing P/E ratio stands at 27.99x, with a forward P/E of 10.16x. The 52-week range spans from $17.89 to $41.47; the current price is 54.8% below the yearly high. Year-over-year revenue growth stands at +22.4%. The net profit margin stands at 10.9%.
💰 Dividend
Waystar Holding Corp. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Analyst Rating
23 analysts rate Waystar Holding Corp. (WAY) on consensus: Strong Buy. The average price target is $33.83, implying +80.41% from the current price. Analyst price targets range from $25.00 to $44.00.
Waystar Holding Corp.: The Investment Case in Detail
Waystar Holding Corp. (WAY) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
The Bull Case
Revenue is growing at a healthy 22.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 37.5% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. With a gross margin near 68.72%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.
What to Watch Next
- The forward P/E of 10.16x is meaningfully below the trailing 27.99x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 80.41% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Investment Thesis: Strengths & Weaknesses
- Strong revenue growth of 22.4% YoY
- High gross margin of 68.72% — indicates pricing power
- Analyst consensus: Strong Buy
- Solid balance sheet with low debt (D/E 37.75)
- Positive free cash flow
No significant red flags in current metrics.
Technical Snapshot
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Risk Profile
The data points to relatively defensive market behavior, elevated short interest (6.83%).
Trading Data
Related Stocks in the Same Sector
More Healthcare stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Waystar Holding Corp.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
